Anebulo Pharmaceuticals has an EPS of $-0.47. In 2022, the company made an earnings per share (EPS) of $-0.29. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.47 | 62.07% |
2022 | -$0.29 | -89.75% |
2021 | -$2.83 | - |